SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001070698-14-000013
Filing Date
2014-03-13
Accepted
2014-03-13 16:07:00
Documents
3
Period of Report
2014-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICAL FORM 8-K FILED MARCH 13, 2014 rptp8k031314_fye123113pr.htm 8-K 15212
2 RAPTOR PHARMACEUTICAL PRESS RELEASE DATED MARCH 13, 2013 rptp031314_fye123113prrls.htm EX-99.1 265851
3 image00001.jpg GRAPHIC 4763
  Complete submission text file 0001070698-14-000013.txt   289176
Mailing Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949
Business Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25571 | Film No.: 14691075
SIC: 2834 Pharmaceutical Preparations